RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
0.9729
-0.0029 (-0.30%)
At close: May 28, 2025, 4:00 PM
0.9500
-0.0229 (-2.35%)
Pre-market: May 29, 2025, 7:24 AM EDT
RAPT Therapeutics Stock Forecast
RAPT's stock price has decreased by -76.72% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for RAPT Therapeutics stock ranges from a low of $1.00 to a high of $10. The average analyst price target of $5.25 forecasts a 439.62% increase in the stock price over the next year.
Price Target: $5.25 (+439.62%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for RAPT Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Buy | 2 | 2 | 2 | 1 | 1 | 1 |
Hold | 6 | 6 | 6 | 4 | 4 | 1 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 10 | 10 | 10 | 7 | 7 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
UBS | UBS | Hold Maintains $2 → $1 | Hold | Maintains | $2 → $1 | +2.79% | May 22, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +516.71% | May 22, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +927.85% | Mar 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $10 | Hold → Strong Buy | Upgrades | $10 | +927.85% | Dec 26, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 25, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.44
from -3.19
EPS Next Year
-0.70
from -0.44
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | ||
Avg | n/a | n/a | n/a | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.26 | -0.38 | -0.36 | ||
Avg | -0.44 | -0.70 | -0.35 | ||
Low | -0.74 | -0.89 | -0.33 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.